Keikku
    Back to Blog

    How to Quantify ROI in an Age of Physician Burnout

    Posted in Keikku Blog

    By Diana van Stijn, MD PhD

    June 14, 2026


    How to Quantify ROI in an Age of Physician Burnout

    Every health system leader evaluating clinical Artificial Intelligence (AI) eventually hits the same wall. The pitch decks promise transformation, but the Chief Financial Officer (CFO) wants a number. What, exactly, is the return on investment? In an era defined by physician burnout and a worsening clinician shortage, answering that question requires looking past the obvious line items and confronting the single largest hidden cost in modern healthcare: fragmentation. The clearest path to return is augmentation that fights it.

    By Diana van Stijn, MD PhD | Augmented by Keikku AI

    The real cost is burnout, and burnout has a price tag

    Start with what burnout actually costs, because it is measurable. Burnout drives clinicians to cut hours and to leave medicine entirely, and replacing a single physician carries recruitment, onboarding, and lost-productivity costs that run into the hundreds of thousands of dollars. Every departure deepens the shortage and loads more work onto the clinicians who remain, which produces more burnout. It shows up on the balance sheet as turnover expense, locum coverage, reduced patient throughput, and lost revenue from unfilled clinical capacity.

    Administrative burden, not clinical complexity, is the primary driver. Physicians lose roughly a third of the clinical day to the Electronic Health Record (EHR). So the first principle of Return on Investment (ROI) in this environment is simple: anything that gives a clinician time back is not a soft benefit. It is a direct lever on retention, capacity, and revenue. But there is a second principle that most ROI models miss entirely, and it often matters more.

    The fragmentation tax: the cost nobody puts on the invoice

    Here is the cost that never appears as a line item. To assemble a modern augmented clinic, an organization does not buy one thing. It buys many. A vendor for documentation. A different one for evidence lookup. A separate tool for triage. Another for the front desk. Something else again for staffing and shift management. A separate device, or several, for diagnostics. Each is sold as a time-saver. Each, in isolation, may even be one. But the organization and the clinician pay a fragmentation tax to hold the whole thing together, and that tax is large, real, and almost never quantified.

    It compounds in three ways.

    First, multiple pilots. Every new vendor means a new pilot, a new evaluation committee, a new security review, a new clinical champion, and months of staff time before a single dollar of value is realized. Run five pilots and you have five times the procurement overhead and five chances for adoption to stall.

    Second, multiple vendors and stacking prices. Each tool carries its own subscription, its own per-seat pricing, its own contract to negotiate and renew, and its own integration to build and maintain. The headline price of any single tool understates the true cost, because the real bill is the sum of all of them plus the Information Technology (IT) overhead of keeping them connected. Savings promised in isolation get eaten by the cost of the stack.

    Third, the physical and cognitive weight on the clinician. This is the most visible symptom of fragmentation and the most absurd. To run a single ordinary consultation, a clinician is increasingly asked to carry and juggle a pocketful of items and a screenful of logins: one app for the scribe, another tab for evidence, a separate device for auscultation, a different system for triage notes, yet another for messaging. Each demands its own login, its own interface, its own context held in the clinician's head. The cognitive load of switching between them is itself a documented contributor to burnout. A consultation should require a clinician's attention on the patient, not on managing a drawer of half-connected gadgets and a browser full of tabs.

    When you quantify ROI honestly, you subtract this fragmentation tax from the headline savings of every point tool. A platform that consolidates does not just add value. It stops the leak.

    Case study: Quadrivia and the voice-centric front office

    Consider the front desk, the operational layer where fragmentation bites first. Quadrivia, through its assistant Qu, is an example of augmentation aimed squarely here. Built by clinicians to handle clinical and administrative interactions through natural voice, Qu is designed to manage complete patient journeys autonomously, taking the relentless load of inbound calls, scheduling, and routine outreach off human staff.

    The return is concrete. Recovered missed calls and captured appointments convert directly into revenue that would otherwise have walked to a competing practice. Reduced repetitive call-handling lowers the burnout-driven turnover that plagues front-desk roles. And Quadrivia frames its own purpose around the structural imbalance between elastic patient demand and constrained provider supply, the same shortage driving burnout system-wide. This is augmentation of the team, returning value in throughput and access rather than inside any single visit.

    Case study: Infermedica and validated triage

    Now consider the front door to clinical care itself. Infermedica is an example of augmentation built to a regulated, clinically validated standard. Its Medical Guidance Platform is certified as a medical device under European Union Medical Device Regulation, built on a physician-curated knowledge base and validated across more than twenty peer-reviewed studies.

    The operational returns are documented. Infermedica guides patients to the right level of care before they consume a clinician's time on the wrong one, which diverts unnecessary emergency department visits, shortens triage interviews, and aligns care acuity. Each of those is a quantifiable line: diverted low-value visits, clinician hours redirected to patients who need them, and reduced downstream cost. Because it is clinically validated and certified, an organization can place trust in its recommendations appropriately and build it into care pathways with confidence.

    Both Quadrivia and Infermedica return real value. But notice what an organization has after buying both: two more vendors, two more contracts, two more integrations, two more pilots. The value is real and so is the fragmentation tax. The question is whether the clinical core has to add to that tax or can finally subtract from it.

    Where Keikku fits: consolidation, not accumulation

    This is the part of the stack where Keikku is built to deliver return, and it does so on the opposite principle from everything above. Where most augmentation adds another vendor, another login, another item in the pocket, Keikku consolidates the entire clinical core of the encounter onto one platform with one shared patient context.

    The Scribe | AI Notes returns time by lifting documentation off the clinician using Voice AI to generate structured notes with coding. Reference and Clinical Decision Support (CDS) bring referenced answers to the point of decision instead of sending the clinician to yet another separate tool. And Diagnostics AI, including Murmur Detection, adds diagnostic intelligence at the exam itself, reasoning over the same patient context as the Scribe and the Reference engine rather than sitting in a separate product that cannot see them. The documentation, the evidence, and the diagnostic finding describe one patient in one moment, and on Keikku they finally live in one place. Three capabilities that would otherwise mean three vendors, three logins, and three items to carry become one.

    The expansion logic is what makes the return compound without the tax compounding alongside it. Keikku scales from software-only to software-plus-hardware on the same platform. A health system can deploy the Scribe | AI Notes, Reference, and CDS as pure software to its entire clinician base at near-zero marginal cost, capturing documentation and decision-support value organization-wide at the speed of a login, with no new device in anyone's pocket. Then, where the physical exam drives clinical and financial value, the FDA-cleared Keikku device adds full Diagnostics AI and Murmur Detection to the very same platform. The organization does not run a fresh pilot, sign a fresh vendor, or hand clinicians another gadget. It expands what it already has. The single device replaces the drawer.

    A practical way to quantify the return

    Put together, a defensible ROI model for clinical augmentation in the age of burnout has four components. First, the hard time savings, measured in clinician hours returned per day and converted into retention value and recovered clinical capacity. Second, the recovered revenue, from captured appointments, reduced no-shows, fewer inappropriate escalations, and accurate coding. Third, the avoided cost, including the turnover that retention prevents and the agency and overtime spend that better staffing avoids. And fourth, the fragmentation tax avoided, the pilots not run, the contracts not signed, the integrations not built, the items not added to the clinician's pocket, and the cognitive load not added to their day.

    That fourth component is the one most models ignore and the one that often decides the real return. AI-leveraged staffing, a voice-centric front office like Quadrivia, and validated triage like Infermedica each earn their place in the stack. But every one of them is also another vendor in a system already straining under too many. Keikku's contribution is to take the clinical core, documentation, evidence, decision support, and diagnostics, and consolidate it into a single platform that expands from software to hardware without ever fragmenting again. The other tools fight fragmentation at the edges. Keikku removes it from the center. That is where the return lives, and that is how you quantify it.


    Sources

    1. Quadrivia. Company and product overview (Qu, voice-centric clinical and administrative assistant). quadrivia.ai
    2. Quadrivia. "Quadrivia unveils Qu" (beta launch and workforce-shortage framing). quadrivia.ai/press
    3. Infermedica. Clinical AI triage and Medical Guidance Platform overview. infermedica.com
    4. Infermedica. Virtual triage solution and documented operational outcomes. infermedica.com/solutions/triage
    5. Infermedica. Research studies (peer-reviewed validation). infermedica.com/research-studies
    6. American Medical Association. "AI scribe saves doctors an hour at the keyboard every day." ama-assn.org